Substituent-regulated highly X-ray sensitive Os(VI) nitrido complex for low-toxicity radiotherapy
Authors:
- Mingkai ChenMCMingkai Chen
- Xiaoting HuangXHXiaoting Huang
- Jie LaiJLJie Lai
- Li MaLMLi Ma
- Tianfeng ChenTCTianfeng Chen
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Chinese Chemical Letters
- Vol. 32 (1) , 158-161
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (21701054, 21877049)
- Guangdong Natural Science Foundation (2017A030310409)
- Open Fund of the Key Laboratory of Functional Molecular Engineering of Guangdong Province (2017KF06)
- Major Program for Tackling Key Problems of Industrial Technology in Guangzhou (201902020013)
- Pearl River Nova Program of Guangzhou (201906010077)
- Dedicated Fund for Promoting High-Quality Marine Economic Development in Guangdong Province (GDOE-2019-A31, 2020-035)
- Fundamental Research Funds for the Central Universities
- Guangdong Provincial Key Laboratory Fund of Functional Supramolecular Coordination Materials and Applications
- K. C. Wong Education Foundation
This publication has 31 references indexed in Scilit:
- New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effectPhysica Medica, 2014
- A Breast Cancer Stem Cell-Selective, Mammospheres-Potent Osmium(VI) Nitrido ComplexJournal of the American Chemical Society, 2014
- Bidentate Ligands on Osmium(VI) Nitrido Complexes Control Intracellular Targeting and Cell Death PathwaysJournal of the American Chemical Society, 2013
- Synthesis and antitumor activity of a series of osmium(vi) nitrido complexes bearing quinolinolato ligandsChemical Communications, 2013
- Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cellsToxicology in Vitro, 2013
- Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agentsChemical Science, 2012
- Strategies to improve radiotherapy with targeted drugsNature Reviews Cancer, 2011
- Osmium(vi) complexes as a new class of potential anti-cancer agentsChemical Communications, 2011
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI: Journal of the National Cancer Institute, 1991